{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:2336",
      "entity_text" : "BP",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P01241",
      "entity_text" : "GH",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Maison et al. found that GH treatment in GHD significantly reduced C-LDL [-0.5 (SD 0.3) mmol / liter], C-TOT [-0.3 (SD 0.3) mmol / liter], fat mass [-3.1 (SD 3.3) kg], diastolic BP [-1.8 (SD 3.8) mmHg] and significantly increased FFM [+2.8 (SD 2.7) kg], fasting plasma glucose [+ 0.2 (SD 0.1) mM/L], and insulin [+8.7 (SD 7.0) pM/L] [XREF_BIBR].",
  "reading_complete" : "2020-07-28T15:41:35Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T15:32:56Z",
  "trigger" : "reduced",
  "evidence" : [ "GH treatment in GHD significantly reduced C-LDL [-0.5 (SD 0.3) mmol/liter], C-TOT [-0.3 (SD 0.3) mmol/liter], fat mass [-3.1 (SD 3.3) kg], diastolic BP" ],
  "pmc_id" : "5925873",
  "score" : 0
}